Search - tctmd.com

Displaying 161 - 180 of 197

Sort: Relevancy | Date

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Prevail Study: Design and Current Status

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

PFM Medical: Device Description and Preclinical Results

Presenter: Alexander Javois

October 23, 2012

Presentation TCT 2012

Outcomes and Insights from the European ACP Registry

Presenter: Jai-Wun Park

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Presentation TCT 2012

LARIAT Tips and Tricks

Presenter: Steven Yakubov

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

ICE Guidance for LAA Closure: Advantages and Limitations

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Presenter: Mark Reisman

October 23, 2012

Presentation TCT 2012

CT and MRI for Patient Selection and Procedural Guidance

Presenter: Carlos Ruiz

October 23, 2012

Advertisement

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

The New Anticoagulants: A Meaningful Step Forward?

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Prevail Study: Design and Current Status

PFM Medical: Device Description and Preclinical Results

Outcomes and Insights from the European ACP Registry

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Lifetech LAA Closure Device: Description and Preclinical Results

LARIAT Tips and Tricks

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

ICE Guidance for LAA Closure: Advantages and Limitations

How to Become Trained and Start a LAA Closure Program

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

CT and MRI for Patient Selection and Procedural Guidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content